Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Olympus ( (JP:7733) ) has issued an announcement.
Olympus Corporation announced a leadership transition as part of its strategic growth plan. Yasuo Takeuchi, who has been instrumental in transforming Olympus into a global MedTech leader, will step down as Representative Executive Officer, passing the leadership to Keith Boettiger. Boettiger, with extensive experience in sales and regulatory affairs, will continue to drive innovation and growth in the Gastrointestinal Solutions Division, reflecting Olympus’s commitment to advancing its market position and creating new business opportunities.
The most recent analyst rating on (JP:7733) stock is a Buy with a Yen2088.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.
More about Olympus
Olympus Corporation is a leading company in the medical technology industry, primarily focusing on endoscopic devices and gastrointestinal solutions. The company is known for its innovative approaches in the MedTech sector and aims to expand its global presence.
Average Trading Volume: 4,272,655
Technical Sentiment Signal: Sell
Current Market Cap: Yen2087.7B
For a thorough assessment of 7733 stock, go to TipRanks’ Stock Analysis page.